Study on the Protective Effect of Gastrodin on Myocardial Injury in Patients Undergoing Cardiac Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-31

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intends to include hypertrophic cardiomyopathy patients over 18 years old who underwent cardiac surgery in our hospital. Patients were divided into medication group and control group according to the use of gastrodin during operation. The patients ' myocardial tissue samples were collected, the postoperative prognosis data were observed and recorded, and the data were analyzed. The degree of myocardial tissue cell damage and postoperative clinical outcomes were compared between the two groups.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retrospective Study of the Protective Effect of Gastrodin on Myocardium in Patients Undergoing Cardiac Surgery

NCT06012994

Cardiac Surgical Procedures

COMPLETED

Anesthetic Management for TA-BSM in HOCM

NCT06397092

Anesthesia Transapical Beating-heart Septal Myectomy Hypertrophic Cardiomyopathy

COMPLETED

Desflurane vs. Propofol for Cardiac Anesthesia

NCT07116733

Cardiac Surgery Coronary Artery Bypass Grafting

RECRUITING PHASE3

Study on the Effect of Target-controlled Infusion for General Anesthesia in Cardiac Surgery

NCT06012955

Postoperative Mechanical Ventilation Time

UNKNOWN

Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia

NCT06497660

Breast Cancer Neoadjuvant Chemotherapy Perioperative Period +2 more

RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Surgical Procedures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GAS

No interventions assigned to this group

Control

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with hypertrophic cardiomyopathy aged≥18 years, regardless of gender;
* Patients undergoing elective hypertrophic cardiomyopathy outflow tract surgery;
* Signed informed consent, good compliance.

Exclusion Criteria

* suffering from more serious genetic diseases (such as immunodeficiency, thalassemia, etc.);
* moderate to severe malnutrition, moderate to severe anemia;
* persistent infection;
* severe preoperative underlying diseases (such as severe liver and kidney dysfunction)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No